Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial

BACKGROUND: Clinical outcomes of patients with osteosarcoma remain unsatisfactory, with little improvement in a 5-year overall survival over the past three decades. There is a substantial need for further research and development to identify and develop more efficacious agents/regimens in order to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Koonrungsesomboon, Nut, Ngamphaiboon, Nuttapong, Townamchai, Natavudh, Teeyakasem, Pimpisa, Charoentum, Chaiyut, Charoenkwan, Pimlak, Natesirinilkul, Rungrote, Sathitsamitphong, Lalita, Ativitavas, Touch, Chaiyawat, Parunya, Klangjorhor, Jeerawan, Hongeng, Suradej, Pruksakorn, Dumnoensun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106788/
https://www.ncbi.nlm.nih.gov/pubmed/32228535
http://dx.doi.org/10.1186/s12885-020-06751-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106788/
https://www.ncbi.nlm.nih.gov/pubmed/32228535
http://dx.doi.org/10.1186/s12885-020-06751-2

Ejemplares similares